Cys 2 ) or cystine-free/GSH-supplemented (750 M) medium for 48 h, and the relative abundance of indicated intracellular (e-g) and extracellular (f-g) metabolites was determined

Disclosures: Felice Cinque: Nothing to Disclose, Andrea Dalbeni: Nothing to Disclose, Annalisa Cespiati: Nothing to Disclose, Floriana Santomenna: Nothing to Disclose, Jaqueline Curr: Nothing to Disclose, Daniel Smith: Nothing to Disclose, Erika Fatta: Nothing to Disclose, Cristina Bertelli: Nothing to Disclose, Giovanna Oberti: Nothing to Disclose, Giuseppina Pisano: Nothing to Disclose, Gabriele Maffi: Nothing to Disclose, Edoardo Pulixi: Nothing to Disclose, Alessandro Mantovani: Nothing to Disclose, Mirko Zoncap: Nothing to Disclose, David Sacerdoti: Nothing to Disclose, Anna Fracanzani: Nothing to Disclose, Rosa Lombardi: Nothing to Disclose 1130 ASSOCIATION OF BMI TRAJECTORY WITH MORTALITY AMONG NON-ALCOHOLIC FATTY LIVER DISEASE INDIVIDUALS: A PROSPECTIVE COHORT STUDY Junping Shi 1 Pengwei Zhang 1 Xianhui Dong 1 Yixuan Zhu 2 Run zhou 1 Fajuan Rui 2 Jie Li 2 Li Li 1 , 1 The Affiliated Hospital of Hangzhou Normal University, 2 Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School Background: Weight is a dynamically changing physiological indicator, the relationship between historical weight trends and mortality in patients with Non-alcoholic fatty liver disease (NAFLD) remains unclear

Pl-10 7
Strategy by M1G Some of our products are not available to the general public without seeking medical advice